Remember to assess the 'whole' patient: a further immune-related adverse event of programmed cell death 1 checkpoint inhibition
Br J Dermatol
.
2020 Feb;182(2):276-277.
doi: 10.1111/bjd.18716.
Epub 2019 Dec 18.
Author
H J A Hunter
1
Affiliation
1
The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, U.K.
PMID:
31850528
DOI:
10.1111/bjd.18716
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Agents, Immunological*
Apoptosis
Humans
Lipodystrophy, Congenital Generalized*
Programmed Cell Death 1 Receptor
Substances
Antineoplastic Agents, Immunological
Programmed Cell Death 1 Receptor